Research Article
A Ferroptosis-Related LncRNA Signature Associated with Prognosis, Tumor Immune Environment, and Genome Instability in Hepatocellular Carcinoma
Table 1
Clinical characteristics of the patients obtained from TCGA-LIHC dataset.
| | No. of patients | Train cohort | Test cohort | | 219 | 145 |
| | Age (median [IQR]) | 62.00 [51.00, 70.00] | 61.00 [52.00, 68.00] | | Sex (%) | | | | Female | 73 (33.3) | 46 (31.7) | | Male | 146 (66.7) | 99 (68.3) | | Stage (%) | | | | Stage I | 106 (48.4) | 63 (43.4) | | Stage II | 52 (23.7) | 32 (22.1) | | Stage III | 46 (21.0) | 37 (25.5) | | Stage IV | — | 4 (2.8) | | Unknown | 15 (6.8) | 9 (6.2) | | (%) | | | | T1 | 114 (52.1) | 65 (44.8) | | T2 | 54 (24.7) | 37 (25.5) | | T3 | 42 (19.2) | 36 (24.8) | | T4 | 6 (2.7) | 7 (4.8) | | Unknown | 3 (1.4) | — | | (%) | | | | N0 | 143 (65.3) | 104 (71.7) | | N1 | 2 (0.9) | 2 (1.4) | | Unknown | 74 (33.8) | 39 (26.9) | | (%) | | | | M0 | 155 (70.8) | 107 (73.8) | | M1 | — | 3 (2.1) | | Unknown | 64 (29.2) | 35 (24.1) | | Grade (%) | | | | G1 | 34 (15.5) | 21 (14.5) | | G2 | 110 (50.2) | 65 (44.8) | | G3 | 66 (30.1) | 51 (35.2) | | G4 | 6 (2.7) | 6 (4.1) | | Unknown | 3 (1.4) | 2 (1.4) | | Vital status (%) | | | | Alive | 140 (63.9) | 94 (64.8) | | Dead | 79 (36.1) | 51 (35.2) |
|
|
TCGA: The Cancer Genome Atlas, LIHC: liver hepatocellular carcinoma, IQR: interquartile range.
|
